Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Dall'Era

Showing results (31-40 of 125) with videos related to

Pageof 13
Sort By:
Arthritis Care & Research|August 3, 2020
Major Depression and Adverse Patient-Reported Outcomes in Systemic Lupus Erythematosus: Results From a Prospective Longitudinal CohortBrett Dietz, Patricia Katz, Maria Dall'Era, et al.
American Journal of Pharmaceutical Education|April 1, 2020
A Mobile Learning Module to Support Interprofessional Knowledge Construction in the Health ProfessionsLeslie Carstensen Floren, Jennifer Mandal, Maria Dall'Era, et al.
MMWR. Morbidity and Mortality Weekly Report|February 18, 2021
Mortality Among Minority Populations with Systemic Lupus Erythematosus, Including Asian and Hispanic/Latino Persons - California, 2007-2017Milena A Gianfrancesco, Maria Dall'Era, Louise B Murphy, et al.
RMD Open|September 14, 2023
Differential regulation of the interferon response in systemic lupus erythematosus distinguishes patients of Asian ancestryIan Rector, Katherine A Owen, Prathyusha Bachali, et al.
The Lancet. Rheumatology|January 30, 2024
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trialsEric F Morand, Richard A Furie, Ian N Bruce, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2015
Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohortMaria Dall'Era, Miriam G Cisternas, Dawn E Smilek, et al.
Frontiers in Medicine|June 7, 2022
The Impact of Telemedicine on Rheumatology CareWei Tang, Sean Inzerillo, Julia Weiner, et al.
Arthritis Care & Research|December 18, 2020
High Disease Severity Among Asian Patients in a US Multiethnic Cohort of Individuals With Systemic Lupus ErythematosusKimberly DeQuattro, Laura Trupin, Louise B Murphy, et al.
Journal of Managed Care & Specialty Pharmacy|October 3, 2022
Real-world treatment utilization and economic implications of lupus nephritis disease activity in the United StatesMaria Dall'Era, Kenneth Kalunian, Michael Eaddy, et al.
Lupus Science & Medicine|May 19, 2025
Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trialsAnca D Askanase, Edward M Vital, Oliver Meier, et al.
Pageof 13

Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
Arthritis Care & Research|August 3, 2020
Major Depression and Adverse Patient-Reported Outcomes in Systemic Lupus Erythematosus: Results From a Prospective Longitudinal CohortBrett Dietz, Patricia Katz, Maria Dall'Era, et al.
American Journal of Pharmaceutical Education|April 1, 2020
A Mobile Learning Module to Support Interprofessional Knowledge Construction in the Health ProfessionsLeslie Carstensen Floren, Jennifer Mandal, Maria Dall'Era, et al.
MMWR. Morbidity and Mortality Weekly Report|February 18, 2021
Mortality Among Minority Populations with Systemic Lupus Erythematosus, Including Asian and Hispanic/Latino Persons - California, 2007-2017Milena A Gianfrancesco, Maria Dall'Era, Louise B Murphy, et al.
RMD Open|September 14, 2023
Differential regulation of the interferon response in systemic lupus erythematosus distinguishes patients of Asian ancestryIan Rector, Katherine A Owen, Prathyusha Bachali, et al.
The Lancet. Rheumatology|January 30, 2024
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trialsEric F Morand, Richard A Furie, Ian N Bruce, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2015
Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohortMaria Dall'Era, Miriam G Cisternas, Dawn E Smilek, et al.
Frontiers in Medicine|June 7, 2022
The Impact of Telemedicine on Rheumatology CareWei Tang, Sean Inzerillo, Julia Weiner, et al.
Arthritis Care & Research|December 18, 2020
High Disease Severity Among Asian Patients in a US Multiethnic Cohort of Individuals With Systemic Lupus ErythematosusKimberly DeQuattro, Laura Trupin, Louise B Murphy, et al.
Journal of Managed Care & Specialty Pharmacy|October 3, 2022
Real-world treatment utilization and economic implications of lupus nephritis disease activity in the United StatesMaria Dall'Era, Kenneth Kalunian, Michael Eaddy, et al.
Lupus Science & Medicine|May 19, 2025
Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trialsAnca D Askanase, Edward M Vital, Oliver Meier, et al.
Pageof 13